• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

垂体手术中眶上锁孔入路(KSA)与鼻内镜经蝶入路(EETA)的比较结果

Comparative outcomes of keyhole supraorbital approach (KSA) and endonasal endoscopic transsphenoidal approach (EETA) in pituitary surgery.

作者信息

Wongsirisuwan Methee, Karnchanapandh Krissanee

出版信息

J Med Assoc Thai. 2014 Apr;97(4):386-92.

PMID:24964680
Abstract

BACKGROUND

Currently, minimal invasive surgery (the endonasal endoscopic transsphenoidal approach-EETA or keyhole supraorbital approach-KSA) is widely accepted as the best choice for pituitary tumor removal. To the best of the authors' knowledge, there is no study comparing the relative safety of these methods.

OBJECTIVE

To evaluate safety and compare the complications resulting from pituitary surgery using EETA and KSA.

MATERIAL AND METHOD

The retrospective review was performed between January 2003 and September 2013. One hundred thirty patients with pituitary adenomas were operated by using either EETA or KSA. The KSA was used on 92 cases, and the EETA was utilized on the other 38. Postoperative complications were analyzed using statistical methodologies to show statistical significance. The study was approved by the ethical committee of Rajavithi Hospital.

RESULTS

After statistical analysis, KSA provided better outcome in term of "headache improvement" than EETA. For complications, EETA had higher incidences of unimproved vision and reoperation rate than KSA. The other major finding of the present study was that in the early year of the operations, there was higher incidence of complications. This could be associated with the level of skills of the surgeons.

CONCLUSION

KSA had better outcome in term of operative time, length of hospital stay, estimated blood loss, and headache improvement than EETA. For complications, EETA had higher incidence of unimproved vision and reoperation rate than KSA.

摘要

背景

目前,微创手术(鼻内镜经蝶窦入路-EETA或眶上锁孔入路-KSA)被广泛认为是垂体瘤切除的最佳选择。据作者所知,尚无研究比较这些方法的相对安全性。

目的

评估垂体手术采用EETA和KSA的安全性并比较其并发症。

材料与方法

回顾性分析2003年1月至2013年9月期间的病例。130例垂体腺瘤患者接受了EETA或KSA手术。92例采用KSA,另外38例采用EETA。采用统计学方法分析术后并发症以显示统计学意义。本研究经拉贾维提医院伦理委员会批准。

结果

经统计学分析,KSA在“头痛改善”方面比EETA效果更好。在并发症方面,EETA视力未改善的发生率和再次手术率高于KSA。本研究的另一主要发现是,在手术早期,并发症发生率较高。这可能与外科医生的技术水平有关。

结论

在手术时间、住院时间、估计失血量和头痛改善方面,KSA比EETA效果更好。在并发症方面,EETA视力未改善的发生率和再次手术率高于KSA。

相似文献

1
Comparative outcomes of keyhole supraorbital approach (KSA) and endonasal endoscopic transsphenoidal approach (EETA) in pituitary surgery.垂体手术中眶上锁孔入路(KSA)与鼻内镜经蝶入路(EETA)的比较结果
J Med Assoc Thai. 2014 Apr;97(4):386-92.
2
What is the better minimally invasive surgery in pituitary surgery: endoscopic endonasal transsphenoidal approach or keyhole supraorbital approach?在垂体手术中,哪种微创手术更好:鼻内镜经蝶窦入路还是眶上锁孔入路?
J Med Assoc Thai. 2011 Jul;94(7):888-95.
3
Pure Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Adenomas in the Elderly: Surgical Outcomes and Complications in 158 Patients.老年无功能垂体腺瘤的单纯内镜鼻内经蝶窦入路:158例患者的手术结果及并发症
World Neurosurg. 2015 Dec;84(6):1572-8. doi: 10.1016/j.wneu.2015.08.035. Epub 2015 Sep 1.
4
Fully endoscopic combined transsphenoidal and supraorbital keyhole approach for parasellar lesions.经蝶窦及眶上锁孔联合内镜入路切除鞍旁病变
J Neurosurg. 2018 Mar;128(3):685-694. doi: 10.3171/2016.11.JNS161833. Epub 2017 Apr 28.
5
[Endoscopic endonasal transsphenoidal approach for pituitary adenomas].[经鼻内镜经蝶窦入路治疗垂体腺瘤]
Zhonghua Wai Ke Za Zhi. 2006 Nov 15;44(22):1551-4.
6
Endoscopic endonasal transsphenoidal surgery for invasive pituitary adenoma.经鼻内镜经蝶窦手术治疗侵袭性垂体腺瘤。
J Clin Neurosci. 2008 Mar;15(3):241-5. doi: 10.1016/j.jocn.2007.03.008. Epub 2008 Jan 22.
7
Hemorrhagic pituitary macroadenoma: characteristics, endoscopic endonasal transsphenoidal surgery, and outcomes.出血性垂体大腺瘤:特征、神经内镜经鼻蝶窦手术及预后。
Ann Surg Oncol. 2011 Jan;18(1):246-52. doi: 10.1245/s10434-010-1243-5. Epub 2010 Aug 12.
8
Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series.经鼻内镜单纯入路治疗垂体腺瘤:200例患者的早期手术结果及与既往显微手术系列的比较
Neurosurgery. 2008 May;62(5):1006-15; discussion 1015-7. doi: 10.1227/01.neu.0000325862.83961.12.
9
Results and risk factors for recurrence following endoscopic endonasal transsphenoidal surgery for pituitary adenoma.垂体腺瘤经鼻内镜经蝶窦手术术后的复发结果及危险因素
Clin Neurol Neurosurg. 2014 Apr;119:75-9. doi: 10.1016/j.clineuro.2014.01.020. Epub 2014 Jan 27.
10
Surgical management of selected pituitary macroadenomas using extended endoscopic endonasal transsphenoidal approach: early experience.采用扩展内镜经鼻蝶窦入路治疗特定垂体大腺瘤的手术治疗:早期经验。
Neurol India. 2013 Mar-Apr;61(2):122-30. doi: 10.4103/0028-3886.111114.

引用本文的文献

1
Cosmetic Outcomes of Supraorbital Keyhole Craniotomy Via Eyebrow Incision: A Systematic Review and Meta-Analysis.经眉切口眶上锁孔开颅术的美容效果:一项系统评价和荟萃分析
J Neurol Surg B Skull Base. 2022 Sep 15;84(5):470-498. doi: 10.1055/s-0042-1755575. eCollection 2023 Oct.
2
Minimally invasive keyhole techniques for resection of giant intracranial tumors.用于切除巨大颅内肿瘤的微创锁孔技术
Chin Neurosurg J. 2022 Aug 5;8(1):19. doi: 10.1186/s41016-022-00289-x.
3
Pituitary Hormonal Status after Endoscopic Endonasal Transphenoidal Removal of Nonfunctioning Pituitary Adenoma: 5 years' Experience in a Single Center.
经鼻内镜经蝶窦切除无功能垂体腺瘤后的垂体激素状态:单中心5年经验
Asian J Neurosurg. 2021 Mar 20;16(1):62-66. doi: 10.4103/ajns.AJNS_386_20. eCollection 2021 Jan-Mar.
4
Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis.内镜与显微镜下经蝶窦手术治疗垂体腺瘤的全切除率:一项荟萃分析。
Acta Neurochir (Wien). 2018 May;160(5):1005-1021. doi: 10.1007/s00701-017-3438-z. Epub 2018 Jan 6.
5
Visual outcomes after endoscopic endonasal pituitary adenoma resection: a systematic review and meta-analysis.内镜经鼻垂体腺瘤切除术的视觉预后:系统评价和荟萃分析。
Pituitary. 2017 Oct;20(5):539-552. doi: 10.1007/s11102-017-0815-9.